Key result
TEXTMEDS trial evaluates text messaging to improve post-ACS medication adherence.
RCT (n=1,400)
Single-blind
1:1 allocation ratio via centralized computerized program
Yes
Answers are grounded in this paper and cite their sources.
Randomized trial investigates text message program impact on medication adherence in patients post-ACS, suggesting new adherence strategies.
BACKGROUND: Identifying simple, low-cost and scalable means of supporting lifestyle change and medication adherence for patients following a cardiovascular (CV) event is important. OBJECTIVE: The TEXTMEDS (TEXT messages to improve MEDication adherence and Secondary prevention) study aims to investigate whether a cardiac education and support programme sent via mobile phone text message improves medication adherence and risk factor levels in patients following an acute coronary syndrome (ACS). STUDY DESIGN: A single-blind, multicentre, randomised clinical trial of 1400 patients after an ACS with 12 months follow-up. The intervention group will receive multiple weekly text messages that provide information, motivation, support to adhere to medications, quit smoking (if relevant) and recommendations for healthy diet and exercise. The primary endpoint is the percentage of patients who are adherent to cardioprotective medications and the key secondary outcomes are mean systolic blood pressure (BP) and low-density lipoprotein cholesterol. Secondary outcomes will also include total cholesterol, mean diastolic BP, the percentage of participants who are adherent to each cardioprotective medication class, the percentage of participants who achieve target levels of CV risk factors, major vascular events, hospital readmissions and all-cause mortality. The study will be augmented by formal economic and process evaluations to assess acceptability, utility and cost-effectiveness. SUMMARY: The study will provide multicentre randomised trial evidence of the effects of a text message-based programme on cardioprotective medication adherence and levels of CV risk factors. ETHICS AND DISSEMINATION: Primary ethics approval was received from Western Sydney Local Health District Human Research Ethics Committee (HREC2012/12/4.1 (3648) AU RED HREC/13/WMEAD/15). Results will be disseminated via peer-reviewed publications and presentations at international conferences. TRIAL REGISTRATION NUMBER: ACTRN12613000793718; Pre-results.
No takes yet. Share an insight, caveat, or question.
Chow et al. (2018) conducted an RCT in Acute Coronary Syndrome (ACS) (n=1,400). TEXTMEDS text message program vs. Standard care was evaluated on Percentage of patients adherent to all indicated cardioprotective medications (taking medications on >80% of days) at both 6-month and 12-month visits. The TEXTMEDS text message intervention is being evaluated in a randomized clinical trial of 1,400 patients to determine if it improves medication adherence following acute coronary syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: